Source comparison
Thymosin Alpha 1 Same as Thymosin Alpha-1: Comparison
Before comparing thymosin alpha 1 to thymosin alpha-1, understand this: you're comparing a single entity to itself. The table below clarifies the nomenclature equivalence across the attributes researchers typically verify when sourcing peptides. | Attribute |
This comparison does not assign a generated winner or score.
- Before comparing thymosin alpha 1 to thymosin alpha-1, understand this: you're comparing a single entity to itself. The table below clarifies the nomenclature equivalence across the attributes researchers typically verify when sourcing peptides.
- | Attribute | Thymosin Alpha 1 | Thymosin Alpha-1 | Professional Assessment ||—|—|—|| Amino Acid Sequence | Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN (28 residues) | Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN (28 residues) | Identical. No variation in sequence, acetylation, or chain length || CAS Number | 62304-98-7 | 62304-98-7 | Same chemical registry identifier. Definitive proof of equivalence || Molecular Weight | 3,108.3 Da | 3,108.3 Da | Mass spec confirms identical molecular mass regardless of name || Mechanism of Action | TLR9 agonist, T-cell maturation via MyD88 pathway | TLR9 agonist, T-cell maturation via MyD88 pathway | No functional difference. Receptor binding and downstream signalling are unchanged || Approved Use (Zadaxin) | Immunomodulation in hepatitis B, hepatitis C, sepsis protocols (35+ countries) | Immunomodulation in hepatitis B, hepatitis C, sepsis protocols (35+ countries) | Same regulatory approvals under both naming conventions || Typical Research Dose | 1.6 mg subcutaneously 2×/